Skip to content

Effect of Ozonated Oil as a Desensitizer Prior to In-Office Dental Bleaching – Clinical, Randomized, Blind Study

Influence of different Desensitizing Protocols on Sensitivity control after Tooth Bleaching: clinical, blinded and randomized study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-76dknt8
Enrollment
Unknown
Registered
2023-11-16
Start date
2022-10-20
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dentin Sensitivity

Interventions

The present study is a randomized, double-blind, split-mouth clinical trial that will evaluate the performance of different desensitizing protocols prior to in-office tooth bleaching with 35% hydrogen

Sponsors

Universidade Estadual do Oeste do Paraná
Lead Sponsor
Universidade Estadual do Oeste do Paraná
Collaborator

Eligibility

Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Patients of both sexes; age between 18 and 35 years; presence of all vital anterior teeth; never bleached or restored; have central incisors of A2 color or darker

Exclusion criteria

Exclusion criteria: Patients with missing anterior teeth; affected by caries lesions; presence of recession; some type of restorative or prosthetic treatment; had a history of dental hypersensitivity; had tooth discoloration by tetracycline or flourose; they used many medications; who fit the status of pregnant or lactating

Design outcomes

Primary

MeasureTime frame
It is expected to find a significant difference with less dental sensitivity in the hemi-arch that received ozonized sunflower oil prior to tooth whitening.

Secondary

MeasureTime frame
It is expected to observe a significant difference in tooth color after tooth whitening.

Countries

Brazil

Contacts

Public ContactBruno Dalbosco

Colegiado de Odontologia da Universidade Estadual do Oeste do Paraná - UNIOESTE

brunodalbosco@outlook.com+55-045-998578504

Outcome results

None listed

Source: REBEC (via WHO ICTRP)